Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Nov 7, 2012 · 10-Q · 38 days after period end · 0001193125-12-457533
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Net Income | -$49.55M | -$4.02M | -$7.29M |
| EPS Diluted | -$2.17 | -$0.18 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 7, 2012 · 38 d after period end
